Seroepidemiology of toxoplasmosis in renal patients

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 42, Issue 2, 2011, Pages 237-247

  Nissapatorn, Veeranoot ^a   Leong, Teoh Hoe ^a   Lee, Rogan ^b   Init Ithoi, ^a   Ibrahim, Jamaiah ^a   Yen, Tan Si ^c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

Malaysia; Renal patients; Seroepidemiology; Toxoplasmosis

Indexed keywords

ANTIBODY;

ADULT; AGE; AGED; ANIMAL; ARTICLE; BLOOD; BLOOD TRANSFUSION; CAT; CHRONIC KIDNEY FAILURE; COOKING; CROSS-SECTIONAL STUDY; EATING; EDUCATIONAL STATUS; EPIDEMIOLOGY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALAYSIA; MALE; MARRIAGE; MEAT; MIDDLE AGED; PARASITOLOGY; PREVALENCE; PROSPECTIVE STUDY; RACE; RISK FACTOR; TOXOPLASMA; TOXOPLASMOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES; BLOOD TRANSFUSION; CATS; CONTINENTAL POPULATION GROUPS; COOKING; CROSS-SECTIONAL STUDIES; EATING; EDUCATIONAL STATUS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALAYSIA; MALE; MARITAL STATUS; MEAT; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS; YOUNG ADULT;

EID: 80051555984     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abbas MM, Zaki M, Afify NA. Prevalence of Toxoplasma gondii and cytomegalovirus antibodies in patients with chronic renal failure. J Egypt Soc Parasitol 1996; 26: 671-676.
2. Al-Amari OM. Prevalence of antibodies to Toxoplasma gondii among blood donors in Abha, Asir Region, south-western Saudi Arabia. J Egypt Public Health Assoc 1994; 69: 77-88.
3. Aubert D, Foudrinier F, Villena I, Pinon JM, Biava MF, Renoul E. PCR for diagnosis and follow-up of two cases of disseminated toxoplasmosis after kidney grafting. J Clin Microbiol 1996; 34: 1347.
4. Barsoum RS. Parasitic infections in organ transplantation. Exp Clin Transplant 2004; 2: 258-267.
5. Carme B, Bissuel F, Ajzenberg D, et al. Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J Clin Microbiol 2002; 40: 4037-44.
6. Choi WY, Nam HW, Kwak NH, et al. Foodborne outbreaks of human toxoplasmosis. J Infect Dis 1997; 175: 1280-1292.
7. Da Cunha S, Ferreira E, Ramos I, et al. Cerebral toxoplasmosis after renal transplantation. Case report and review. Acta Med Port 1994; 7: S61-S66.
8. Derouin F, Debure A, Godeaut E, Lariviere M, Kreis H. Toxoplasma antibody titers in renal transplant recipients. Pre-transplant evaluation and post-transplant follow-up of 73 patients. Transplantation 1987; 44: 515-518.
9. Ekweozor CC, Okpala LE, Bamgboye AE, Jegede O. Toxoplasmosis: anti-Toxoplasma IgG antibody levels in patients with lymphoid neoplasia in Ibadan, Nigeria. Afr J Med Sci 1994; 23: 347-353.
10. Ertug S, Okyay P, Turkmen M, Yuksel H. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 2005; 5: 66.
11. Ferreira MS, Borges AS. Some aspects of protozoan infections in immunocompromised patients- a review. Mem Inst Oswaldo Cruz 2002; 97: 443-457.
12. Figueiredo JF, Moyses-Neto M, Gomes UA, et al. Antibody titers to Toxoplasma gondii in renal transplant patients. Braz J Med Biol Res 1983; 16: 235-9.
13. Giordano LF, Lasmar EP, Tavora ER, Lasmar MF. Toxoplasmosis transmitted via kidney allograft: case report and review. Transplant Proc 2002; 34: 498-489.
14. Gourishankar S, Doucette K, Fenton J, Purych D, Kowalewska-Grochowska K, Preiksaitis J. The use of donor and recipient screening for Toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation 2008; 85: 980-985.
15. Iqba, J, Nampoory MR, Johnv KV, Khalid N, Al-Mousawi M. Determination of antibo-dies to Toxoplasma gondii and CMV in renal transplant recipients. Transplant Proc 2003; 35: 2703-2705.
16. Johnson JD, Butcher PD, Savva D, Holliman RE. Application of the polymerase chain reaction to the diagnosis of human toxoplasmosis. J Infect 1993; 26: 147-158.
17. Khalifa Kel-S, Roth A, Roth B, Arasteh KN, Janitschke K. Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol 1994; 32: 2813-2819.
18. Lewis JS Jr, Khoury H, Storch GA, DiPersio J. PCR for the diagnosis of toxoplasmosis after hematopoietic stem cell transplantation. Expert Rev Mol Diagn 2002; 2: 616-624.
19. Lin YL, Liao YS, Liao LR, Chen FN, Kuo HM, He S. Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol Res 2008; 103: 67-74.
20. Lindström I, Kaddu-Mulindwa DH, Kironde F, Lindh J. Prevalence of latent and reactivated Toxoplasma gondii parasites in HIV-patients from Uganda. Acta Trop 2006; 100: 218-222.
21. Magaldi C, Elkis H, Pattoli D, Coscina AL. Epidemic of toxoplasmosis at a university in São-José-dos Campos, S.P. Brazil. 1. Clinical and serologic data. Rev Latinoam Microbiol Parasitol (Mex) 1969; 11: 5-13.
22. Martínez Sánchez R, Machín Sánchez R, Fachado Carvajales A, Pividal Grana J, Cruz de la Paz R, Suárez Hernández M. Several results of a Toxoplasma survey. Invest Clin 1991; 32: 13-26 (in Spanish).
23. Nissapatorn V, Kamarulzaman A, Init I, et al. Seroepidemiology of toxoplasmosis among HIV-infected patients and healthy blood donors. Med J Malaysia 2002; 57: 304-310.
24. Nissapatorn V, Lee C, Lim YAL, et al. Toxoplasmosis: a silent disease in HIV/AIDS patients. Res J Parasitol 2007; 2: 23-31.
25. Nissapatorn V, Lee C, Quek KF, Leong CL, Mahmud R, Khairul Anuar A. Toxoplasmosis in HIV/AIDS patients: a current situation. Jpn J Infect Dis 2004; 57: 160-165.
26. Nissapatorn V, Noor Azmi MA, Cho SM, et al. Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol 2003; 23: 618-624.
27. Nissapatorn V, Wattanagoon Y, Pungpak S, et al. Seroprevalence of toxoplasmosis in HIV infected patients in Chonburi Regional Hospital, Chonburi, Thailand. Trop Biomed 2001; 18: 123-129.
28. Ocak S, Duran N, Eskiocak AF, Aytac H. Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey. Saudi Med J 2005; 26: 1378-1382.
29. Pinon JM, Foudrinier F, Mougeot G, et al. Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients. J Clin Microbiol 1995; 33: 878-884.
30. Pordeus V, Barzilai O, Sherer Y, et al. A latitudinal gradient study of common anti-infectious agent antibody prevalence in Italy and Colombia. Isr Med Assoc J 2008; 10: 65-68.
31. Rai SK, Upadhyay MP, Shrestha HG. Toxoplasma infection in selected patients in Kathmandu, Nepal. Nepal Med Coll J 2003; 5: 89-91.
32. Rabinowitz PM, Gordon Z, Odofin L. Pet-related infections. Am Fam Physician 2007; 76: 1314-1322.
33. Ravichandran J, Rahmah N, Kamaruzzaman A, Khairul Anuar A. Toxoplasma gondii antibodies among Malaysian pregnant women: a hospital-base study. Biomed Res 1998; 1: 25-28.
34. Renoult E, Georges E, Biava MF, et al. Toxoplasmosis in kidney transplant recipients: a life-threatening but treatable disease. Transplant Proc 1997; 29: 821-822.
35. Sukthana Y, Chintana T, Damrongkitchaiporn S, Lekkla A. Serological study of Toxoplasma gondii in kidney recipients. J Med Assoc Thai 2001; 84: 1137-1141.
36. Teutsch SM, Juranek DD, Sulzer A, Dubey JP, Sikes RK. Epidemic toxoplasmosis associated with infected cats. N Engl J Med 1979; 300: 695-699.
37. Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA 1993; 269: 76-77.
38. Wreghitt TG, Joynson DHM. Toxoplasma infection in immunosuppressed (HIV-negative) patients. In: Joynson DHM, Wreghitt TG, eds. Toxoplasmosis: A comprehensive clinical guide. Cambridge: Cambridge University Press, 2001: 178-192.
39. Wulf MW, van Crevel R, Portier R, et al. Toxoplasmosis after renal transplantation: implications of a missed diagnosis. J Clin Microbiol 2005; 43: 3544-3547.
40. Yazar S, Demirtas F, Yalçin S, et al. Anti-Toxoplasma gondii antibodies in haemodialysis patients with chronic renal failure. Yonsei Med J 2003; 44: 288-292.